Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Novateor Research Laboratories Days Payable?
Novateor Research LaboratoriesBOM:542771 59 Days Payable is 391.08 as of Mar. 2026, which is 180% above its 10-year median of 139.55. GuruFocus rates BOM:542771 with a GF Score™ of 59/100 and a GF Value™ of ₹83.64. The stock has 2 warning signs investors should review. Among 1,893 Consumer Packaged Goods companies, Novateor Research Laboratories ranks better than 92.6% on this metric.
The historical rank and industry rank for Novateor Research Laboratories's Days Payable or its related term are showing as below:
BOM:542771'
s Days Payable Range Over the Past 10 Years
Min: 30.41 Med: 139.55 Max: 1117.12
Current: 166.07
During the past 10 years, Novateor Research Laboratories's highest Days Payable was 1117.12. The lowest was 30.41. And the median was 139.55.
BOM:542771's Days Payable is ranked better than 92.6% of 1893
companies
in the Consumer Packaged Goods industry
Industry Median: 43.93
vs BOM:542771: 166.07
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:542771 vs PG, CL, KVUE: Days Payable Comparison
For the Household & Personal Products subindustry, Novateor Research Laboratories's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novateor Research Laboratories Days Payable vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Novateor Research Laboratories's Days Payable distribution charts can be found below:
* The bar in red indicates where Novateor Research Laboratories's Days Payable falls into.
Novateor Research Laboratories Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novateor Research Laboratories (BOM:542771) has a Days Payable of 391.08 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Novateor Research Laboratories and its competitors. This is 180% above median its historical median of 139.55. Over the past decade, Novateor Research Laboratories' Days Payable has ranged from 30.41 to 1,117.12. According to the industry distribution chart, Novateor Research Laboratories ranks #140 out of 1893 companies in the Consumer Packaged Goods industry, placing it in the top 7.4%.
Is Novateor Research Laboratories' Days Payable too high?
Novateor Research Laboratories' current Days Payable of 391.08 is 180% above median its 10-year median of 139.55. Over the past 10 years, this metric has ranged from a low of 30.41 to a high of 1,117.12. The Consumer Packaged Goods industry median Days Payable is 43.93. Novateor Research Laboratories' value of 391.08 is 790.2% above this industry median. Based on the distribution chart, Novateor Research Laboratories ranks #140 out of 1893 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Novateor Research Laboratories has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Novateor Research Laboratories' Days Payable compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Novateor Research Laboratories ranks #140 out of 1893 companies for Days Payable. This places Novateor Research Laboratories in the top 7% of its industry — outperforming the majority of peers. The industry median Days Payable is 43.93. Novateor Research Laboratories' value of 391.08 is 790.2% above this benchmark. Historically, Novateor Research Laboratories' own Days Payable has ranged from 30.41 to 1,117.12 over the past decade. While the company's 10-year median is 139.55 vs. the industry median of 43.93, Novateor Research Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Consumer Packaged Goods company?
The median Days Payable among Consumer Packaged Goods companies is 43.93, based on 1,893 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Novateor Research Laboratories's current Days Payable of 391.08 is 790.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Novateor Research Laboratories and its competitors. For the Consumer Packaged Goods industry, the median Days Payable is 43.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novateor Research Laboratories's current Days Payable is 391.08, which is 180% above median its own 10-year median of 139.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novateor Research Laboratories stock overvalued right now?
Novateor Research Laboratories (BOM:542771) has a current Days Payable of 391.08. The stock's GF Value™ is ₹83.64, compared to a current price of ₹32.85 — trading 60.7% below its estimated fair value. The current Days Payable is 391.08, which is 180% above median its 10-year median of 139.55 and 790.2% above the Consumer Packaged Goods industry median of 43.93. Novateor Research Laboratories' overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Novateor Research Laboratories (BOM:542771), the current Days Payable is 391.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Novateor Research Laboratories (BOM:542771) Overvalued in 2026?
Based on GuruFocus' analysis, Novateor Research Laboratories stock appears to be undervalued.
The current stock price of ₹32.85 is trading 60.7% below its estimated GF Value™ of ₹83.64.
Key valuation signals for BOM:542771:
Days Payable: 391.08 (180% above median its 10-year median of 139.55)
GF Value™: ₹83.64 vs. price of ₹32.85 (60.7% below fair value)
Industry Position: 790.2% above the Consumer Packaged Goods median (#140 of 1893)
No single metric tells the full story. See the BOM:542771 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Novateor Research Laboratories Ltd is a company engaged in the development of novel personal care products that are intended to provide safe, easy, and innovative approaches to the existing traditional personal care solutions. The company's teeth-whitening products are sold under the brand name SmiloShine. The company manufactures three different variants of teeth whitening strips, teeth whitening toothpaste and brush, kids's toothpaste and tongue cleaner, and teeth whitening gel.
59GF Score
Get the complete analysis for BOM:542771
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542771 has been successfully added to your 
